Skip to content

Clinical trials

Phase 3 Stomach Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 3 Country / region: Canada Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20051
20092
20122
20131
20141
20162
20171
20184
20211
20224
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting4
Recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Astellas Pharma Global Development, Inc.2
AstraZeneca2
Hoffmann-La Roche2
Merck Sharp & Dohme LLC2
Taiho Oncology, Inc.2
Alliance for Clinical Trials in Oncology1
Arcus Biosciences, Inc.1
Bristol-Myers Squibb1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms24
Esophageal Neoplasms5
Adenocarcinoma4
Neoplasms3
Lung Neoplasms2
Appendiceal Neoplasms1
Bile Duct Neoplasms1
Carcinoma, Hepatocellular1
Carcinoma, Ovarian Epithelial1
Colonic Neoplasms1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.